Skip to main content

Advertisement

Table 1 Baseline characteristics of all the subjects

From: The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity

Variables CAD (n = 120) nonCAD (n = 90) P DM(n = 37) nonDM (n = 173) P
Male (%) 63.6 57.3 NS 59.8 61.3 NS
Age (years) 63.96 ± 7.85 63.09 ± 8.25 NS 64.32 ± 7.36 63.41 ± 8.18 NS
BMI (kg/m2) 24.17 ± 3.92 24.42 ± 3.02 NS 25.47 ± 3.40 24.00 ± 3.54 0.024
TG (mg/dl) 128.43 ± 71.74 129.32 ± 79.72 NS 147.92 ± 91.23 124.00 ± 69.97 NS
TC (mg/dl) 145.40 ± 35.96 158.16 ± 39.83 0.005 146.95 ± 40.22 151.97 ± 37.51 NS
HDL-C (mg/dl) 40.60 ± 10.05 44.08 ± 11.21 0.028 39.06 ± 9.28 42.92 ± 10.83 NS
LDL-C (mg/dl) 88.16 ± 30.16 97.06 ± 31.32 0.021 88.17 ± 31.32 92.81 ± 30.94 NS
apoAI (g/L) 1.08 ± 0.20 1.17 ± 0.25 0.008 1.08 ± 0.20 1.12 ± 0.23 NS
apoB (g/L) 0.85 ± 0.25 0.89 ± 0.26 NS 0.89 ± 0.28 0.86 ± 0.25 NS
hsCRP (mg/L) 4.93 (1.26–13.44) 2.36 (1.17–7.00) NS 5.12 (1.62–8.28) 3.23 (1.18–11.51) NS
FFA (mmol/L) 0.52 ± 0.29 0.44 ± 0.27 0.047 0.57 ± 0.29 0.46 ± 0.28 0.045
Statin (%) 55.5 3.8 < 0.0001 35.1 32.9 NS
Smoking (%) 46.4 30.5 0.036 37.8 40.0 NS
HF (%) 72.7 42.7 < 0.0001 72.9 57.2 NS
  1. Values are expressed as mean ± SD or median (interquartile range). CAD coronary artery disease, DM diabetes mellitus, BMI body mass index, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, apoAI apolipoprotein AI, apoB apolipoprotein B, hsCRP high sensitivity C reactive protein, FFA free fatty acid, HF heart failure